Exhibit 10.5


 


LOANCORE REALTY TRUST, INC.



INVESTOR RIGHTS AGREEMENT


 


INVESTOR RIGHTS AGREEMENT (this “Agreement”),
dated as of [●] [●], 2015, among LoanCore Realty Trust, Inc., a Maryland corporation (the “Company”),
LoanCore Advisors, LLC, a Delaware limited liability company, LoanCore Capital, LLC, a Delaware limited liability company, LC REIT
LLC, a Delaware limited liability company (the “Investor”), Mark Finerman, Christopher McCormack, Daniel Bennett,
Jordan Bock and Gary Berkman (each of Mark Finerman, Christopher McCormack, Daniel Bennett, Jordan Bock and Gary Berkman, a “Management
Investor” and collectively, the “Management Investors”).


 


WHEREAS, in connection with the IPO (as
defined herein), the Company intends to consummate the transactions described in the Registration Statement on Form S-11 (Registration
No. 333-204154), as amended (the “IPO Registration Statement”);


 


WHEREAS, as an inducement to the Investor
to take such actions as may be necessary or appropriate to cause the IPO to be consummated, the Company, the Management Investors
and the Investor hereby agree that this Agreement shall govern (i) the right of the Investor to nominate up to two (2) director
nominees to the Board (as defined herein) selected by the Investor on the terms set forth herein, (ii) the obligation of the Management
Investors to vote their Common Stock (as defined herein) in favor of the election of the nominee(s) designated by the Investor
and (iii) the right of the Investor to appoint a non-voting observer to the Board on the terms set forth herein;


 


WHEREAS, the Investor hereby agrees that
this Agreement shall govern its obligation to vote its Common Stock in favor of the election of Mark Finerman in any election in
which Mr. Finerman is a director nominee; and


 


WHEREAS, the Company and the Investor desire
to address herein certain relationships between themselves with respect to the composition of the Board and the Investor’s
right to purchase New Securities (as defined herein) in connection with future offerings of New Securities by the Company.


 


NOW, THEREFORE, in consideration of the
mutual covenants and undertakings contained herein and for good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto hereby agree as follows:


 


ARTICLE I


 


DEFINITIONS


 


SECTION 1.1  Definitions. As
used in this Agreement, the following terms shall have the following meanings:


 


“Articles” means the
Articles of Amendment and Restatement of the Company.


 


“Agreement” has the meaning
set forth in the preamble to this Agreement.


 


“Beneficial Owner” of
a security is a Person who directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise
has or shares: (i) voting power, which includes the power to vote, or to direct the voting of, such security and/or (ii) investment
power, which includes the power to dispose of, or to direct the disposition of, such security. The terms “Beneficially
Own” and “Beneficial Ownership” shall have correlative meanings.


 


“Board” means the Board
of Directors of the Company.


 



    	 



    	 



    




“Committee” means the
Nominating and Corporate Governance Committee of the Board.


 


“Common Stock” means
the common stock, par value $0.01 per share, of the Company and any equity securities issued or issuable in exchange for or with
respect to such Common Stock by way of a dividend, split or combination of shares of stock or in connection with a reclassification,
recapitalization, merger, consolidation or other reorganization.


 


“Company” has the meaning
set forth in the preamble to this Agreement.


 


“Failed Offering” has
the meaning set forth in Section 4.4.


 


“Investor” has the meaning
set forth in the preamble to this Agreement.


 


“Investor Affiliate”
has the meaning set forth in Section 2.3.


 


“IPO” means the initial
public offering of Common Stock, as described in the IPO Registration Statement.


 


“IPO Registration Statement”
has the meaning set forth in the recitals to this Agreement.


 


“Management Investor”
has the meaning set forth in the preamble to this Agreement.


 


“New Securities” means
shares of Common Stock, except for the following: (i) the issuance, grant or sale of shares of Common Stock, options to purchase
shares of Common Stock or shares of Common Stock issuable upon the exercise of options or other equity awards pursuant to any equity
incentive plan, stock bonus plan, dividend reinvestment plan or other stock plan or arrangement adopted by the Company; (ii) the
issuance of shares of Common Stock pursuant to the terms of outstanding options, warrants, notes or other rights to acquire shares
of Common Stock of the Company; (iii) the issuance and sale of shares of Common Stock pursuant to an “at the market”
equity distribution program adopted by the Company after a period of one year subsequent to the date of the final prospectus contained
in the IPO Registration Statement; (iv) the issuance of securities by the Company in connection with an acquisition, merger or
purchase of assets; or (v) the issuance and sale of shares of Common Stock in any calendar year in one or more offerings aggregating
less than 1.0% of the issued and outstanding shares of Common Stock.


 


“Observer” has the meaning
set forth in Section 2.3(a).


 


“Person” means any individual,
corporation, firm, partnership, joint venture, limited liability company, estate, trust, business association, organization, any
court, administrative agency, regulatory body, commission or other governmental authority, board, bureau or instrumentality, domestic
or foreign and any subdivision thereof or other entity.


 


“Revenue Letter Agreement”
has the meaning set forth in Section 2.3.


 


SECTION 1.2  Gender. For
the purposes of this Agreement, the words “he,” “his” or “himself” shall be interpreted
to include the masculine, feminine and corporate, other entity or trust form.


 



    	2



    	 



    




ARTICLE II


 


THE INVESTOR’S BOARD REPRESENTATION


 


SECTION 2.1  Initial Board Composition.
As of the date of this Agreement, the Board shall be comprised of five (5) directors, none of whom shall be deemed to have been
designated by the Investor pursuant to Section 2.2. For the avoidance of doubt, the Board shall not be increased to more than 15
directors at any time during the term of this Agreement.


 


SECTION 2.2  Nominees.


 


(a)    Subject to Section 2.2(b), unless this
Agreement is earlier terminated pursuant to Section 6.1, so long as the Investor Beneficially Owns Common Stock representing 5.0%
or more of the Common Stock then outstanding (excluding shares of Common Stock that are subject to issuance upon the exercise or
exchange of rights of conversion or any options, warrants or other rights to acquire shares of Common Stock), the Company agrees
that it shall cause the Committee to recommend to the Board, and the Board to nominate, for election one (1) individual designated
by the Investor to the Board.


 


(b)    Notwithstanding Section 2.2(a), unless
this Agreement is earlier terminated pursuant to Section 6.1, if and for so long as (x) the number of directors comprising the
Board is increased to twelve (12) or more and (y) the Investor Beneficially Owns Common Stock representing 5.0% or more of the
Common Stock then outstanding (excluding shares of Common Stock that are subject to issuance upon the exercise or exchange of rights
of conversion or any options, warrants or other rights to acquire shares of Common Stock), the Company agrees that it shall cause
the Committee to recommend to the Board, and the Board to nominate, for election the two (2) individuals designated by the Investor
to the Board.


 


(c)    For as long as the Investor has the
right to designate at least one individual for nomination by the Board pursuant to this Section 2.2, then, if any such directorship
is vacated by any such designated individual, the Investor shall have the right to designate a replacement individual to the Board
and Sections 2.2(a) and 2.2(b), as applicable, shall govern the obligations of the parties with respect to such individual.


 


(d)    For
as long as the Investor has the right to designate at least one individual for nomination by the Board pursuant to this
Section 2.2, the Investor’s designee(s) shall be entitled to be a member of each committee and sub-committee of the
Board; provided, that, with respect to any such committee or sub-committee of the Board whose members are required to
satisfy the listing standards for independence of the New York Stock Exchange, or such other stock exchange or market on
which the Common Stock is then listed, and/or are required to satisfy other applicable qualifications of the New York Stock
Exchange, or such other stock exchange or market on which the Common Stock is then listed, such designee(s) shall only be
entitled to be a member of such committee or sub-committee if and for so long as such designee(s) satisfies all such
independence requirements and other applicable qualifications.


 


(e)    Members of the Board designated for
nomination by the Investor shall be eligible to receive the compensation payable to, and equity-based awards granted to, non-executive
members of the Board, as well as the reimbursement of travel expenses, unless any such designee is an employee of the Investor
or its affiliate.


 


SECTION 2.3  Observer Rights.


 


(a)    In the event that (i) the Investor
elects not to exercise its right to designate for nomination an individual to serve on the Board pursuant to Section 2.2 or (ii)
the Investor’s Beneficial Ownership of Common Stock falls below 5.0% of the Common Stock then outstanding, the Investor shall
have the right, for so long as one or more of its affiliates (collectively, the “Investor Affiliate”) are entitled
to receive a share of the revenues described in that certain letter agreement dated [●] [●], 2015 among LoanCore Capital,
LLC, LoanCore Advisors, LLC, FINEII Holdings, Inc. and LC Fees LLC (the “Revenue Letter Agreement”), to appoint
a non-voting observer to the Board (the “Observer”), who shall be entitled to attend and participate in all
meetings of the Board and any and all committees thereof.


 



    	3



    	 



    




(b)    For as long as the Investor has the
right to designate an Observer pursuant to this Section 2.3, then, if the designee shall for any reason cease to serve as the Observer,
the Investor shall have the right to designate a replacement Observer and this Section 2.3 shall govern the obligations of the
parties with respect to such individual.


 


(c)    The
Observer shall have all of the rights and privileges of a member of the Board and all committees thereof; provided, that in no
event shall the Observer be deemed to be a member of the Board or such committees or have the right to vote on any matter under
consideration by the Board or such committees. The Observer shall be provided with all notices of meetings, minutes and other materials
provided to members of the Board and/or any and all committees thereof simultaneously with the provision of such materials to the
members of the Board or such committees, as the case may be. All meetings of the Board or committees thereof shall be held in a
manner such that the Observer shall be able to participate therein either in person or telephonically. In the event that the Observer
is unable to attend a meeting of the Board or a committee thereof, the Investor shall have the right to send an alternate in the
Observer’s place to attend such meeting.


 


(d)    The Company shall agree to provide
the Observer (or any subsequent Observer, as the case may be) with the same indemnification and exculpation rights as provided
to members of the Board. The Company shall also obtain and maintain insurance coverage (if available) on behalf of the Observer
(or any replacement thereof) against liability that may be asserted against or incurred by him in his capacity as Observer, which
insurance coverage shall be to the same extent as the insurance coverage provided to the members of the Board.


 


(e)    The right of the Investor to appoint
and maintain an Observer to the Board pursuant to this Section 2.3 shall terminate upon the earlier of (i) the termination of the
Investor Affiliate’s right to receive a share of the revenues described in the Revenue Letter Agreement and (ii) the designation
by the Investor of an individual for nomination to the Board pursuant to Section 2.2 but, in the case of this clause (ii), such
right shall be reinstated if clause (i) of Section 2.3(a) shall again become applicable, provided that such right shall not have
terminated by reason of clause (i) of this sentence.


 


ARTICLE III


 


AGREEMENT TO VOTE


 


SECTION 3.1  Agreement to Vote Common
Stock. Commencing on the date of this Agreement and unless this Agreement is earlier terminated pursuant to Section 6.1, at
every meeting of the stockholders of the Company called with respect to the election of nominees to the Board, and on every action
or approval by written consent of the stockholders of the Company or in any other circumstance in which the vote, consent or approval
of the stockholders of the Company is sought with respect to the election of nominees to the Board, each Management Investor, in
his capacity as a Beneficial Owner of Common Stock, shall appear at the meeting or otherwise cause Common Stock that he Beneficially
Owns (including any Common Stock acquired after the date hereof) to be counted as present thereat for purposes of establishing
a quorum and agrees to vote (or cause to be voted) any and all of such Common Stock or give consent with respect thereto, or cause
consent to be given with respect thereto, in favor of the election to the Board of the nominee(s) designated by the Investor in
accordance with Section 2.2 hereof; and the Investor in its capacity as a Beneficial Owner of Common Stock, shall appear at the
meeting or otherwise cause Common Stock that it Beneficially Owns (including any Common Stock acquired after the date hereof) to
be counted as present thereat for purposes of establishing a quorum and agrees to vote (or cause to be voted) any and all of such
Common Stock or give consent with respect thereto, or cause consent to be given with respect thereto, in favor of the election
to the Board of Mark Finerman. Each party to this Agreement agrees that such party will not (A) grant any proxy, power-of-attorney
or other authorization, in, or with respect to, any Common Stock, or take any other action that would in any way restrict, limit
or interfere with the performance of such party’s obligations hereunder, or (B) directly or indirectly, solicit, initiate,
seek, encourage or support or take any other action the effect of which would be inconsistent with or violative of any provision
contained in this Section 3.1. The parties may vote their respective shares of Common Stock and any other voting securities of
the Company on all other matters in their sole discretion. This Agreement shall not, and shall not be construed to, restrict the
ability of any party to sell or dispose of any Common Stock, in the open market or otherwise.


 


SECTION 3.2  Stockholder Capacity.
Each Management Investor is entering into this Agreement in his capacity as the record and Beneficial Owner of his respective Common
Stock. Notwithstanding any other provision of this Agreement, including Section 3.1, to the extent a Management Investor serves
as an officer or director of the Company, nothing contained herein shall limit his ability to exercise his ordinary and customary
duties as an officer or director of the Company, including the exercise of his fiduciary duties to the Company and its stockholders.
The provisions of this Article III shall not be binding upon the successors in interest to any of the Common Stock other than affiliates
of a Management Investor or the Investor.


 



    	4



    	 



    




ARTICLE IV


 


PREEMPTIVE RIGHTS


 


SECTION 4.1 Sale of New Securities.
Subject to Section 4.6, in connection with any public or non-public offering of New Securities by the Company following the consummation
of the IPO, the Company hereby grants the Investor a preemptive right to acquire from the Company, for the same price offered to
investors in such public or non-public offering and otherwise on the same terms as such New Securities are proposed to be offered
to such investors, up to a number of New Securities equal to its then-proportionate share (based on its percentage of Beneficial
Ownership of the Company, on a fully-diluted basis) of such New Securities. The number of New Securities that the Investor shall
be entitled to purchase in the aggregate shall be determined by multiplying (x) the total number of such offered New Securities
by (y) a fraction, the numerator of which is the number of shares of Common Stock Beneficially Owned by the Investor immediately
prior to the issuance of such offered New Securities, on a fully-diluted basis, assuming full exercise and/or conversion of the
Company’s securities exercisable and/or convertible into the Common Stock, and the denominator of which is the number of
shares of Common Stock then outstanding, on a fully-diluted basis, assuming full exercise and/or conversion of the Company’s
securities exercisable and/or convertible into the Common Stock.


 


SECTION 4.2  Notice. Subject
to Section 4.6, in the event the Company proposes to offer New Securities, it shall give the Investor prior written notice of its
intention, describing the price (or range of prices), anticipated amount of New Securities, timing and other terms upon which the
Company proposes to offer the same to investors in such public or non-public offering, no later than five (5) days prior to the
commencement of such offer or sale, as the case may be. The Investor shall have five (5) days from the date of receipt of such
a notice to notify the Company in writing the extent, if any, to which it intends to exercise such purchase rights and as to the
number of New Securities the Investor desires to purchase. Such notice shall constitute a non-binding indication of interest of
the Investor to purchase the number of New Securities so specified at the price to investors and other terms set forth in the Company’s
notice to it. Subject to Section 4.6, the failure of the Investor to respond within such five (5) day period shall be deemed to
be a waiver of the Investor’s rights under this Article IV only with respect to the offering described in the applicable
notice.


 


SECTION 4.3  Purchase Mechanism.
If the Investor exercises its preemptive rights provided in this Article IV, the closing of the purchase of the New Securities
with respect to which such right has been exercised shall take place simultaneously with the closing of such offering to other
investors. Each of the Company and the Investor agrees to use its commercially reasonable efforts to secure any regulatory or other
consents or stockholder approval, and to comply with any law or regulation necessary in connection with the offer, sale and purchase
of such New Securities.


 


SECTION 4.4  Failure of Purchase.
In the event the Investor fails to exercise its preemptive rights provided in this Article IV within the prescribed period,
the Company shall thereafter be entitled during the period of sixty (60) days following the conclusion of the applicable period
to sell or enter into an agreement (pursuant to which the sale of the New Securities covered thereby shall be consummated, if at
all, within thirty (30) days from the date of said agreement) to sell the New Securities not elected to be purchased pursuant to
this Article IV, at a price and upon terms no more favorable to the purchasers of such securities than were specified in the Company’s
notice to the Investor. Notwithstanding the foregoing, if such sale is subject to the receipt of any regulatory or other consents,
stockholder approval or the expiration of any waiting period, the time period during which such sale may be consummated shall be
extended until the expiration of five (5) business days after all such approvals or consents have been obtained or waiting periods
expired, but in no event shall such time period exceed 180 days from the date of the applicable agreement with respect to such
sale. Subject to Section 4.6, in the event the Company has not sold the New Securities or entered into an agreement to sell the
New Securities within said 60-day period (or sold and issued New Securities in accordance with the foregoing within thirty (30)
days from the date of said agreement (as such period may be extended in the manner described above for a period not to exceed 180
days from the date of said agreement)), the proposed offering of New Securities shall be considered a failed offering (“Failed
Offering”) and the Company shall not thereafter offer, issue or sell such New Securities without first offering such
securities to the Investor in the manner provided above.


 


SECTION 4.5  Cooperation. The
Company and the Investor shall cooperate in good faith to facilitate the exercise of the Investor’s rights hereunder, including
securing any required approvals or consents.


 


SECTION 4.6  Termination of Preemptive
Rights. The preemptive rights set forth in this Article IV shall terminate and be of no further effect upon the date on which
the Investor has failed to (i) exercise its preemptive rights provided in this Article IV within the prescribed period or (ii)
consummate a purchase for which it has exercised its preemptive rights pursuant to Section 4.2 above within the time period specified
in Section 4.3 above; provided, however, that a failure by the Investor to exercise its preemptive rights or consummate
a purchase for which it has exercised its preemptive rights shall not result in a termination of the Investor’s preemptive
rights set forth in this Article IV in the event the offering to which the Investor’s failure relates is a Failed Offering.


 



    	5



    	 



    




ARTICLE V


 


PUBLICITY; CONFIDENTIALITY


 


SECTION 5.1  Publicity. Except
as may be required by applicable law, rule, regulation or order, each of the Company, LoanCore Advisors, LLC and LoanCore Capital,
LLC hereby agrees not to reference (x) the Investor’s name or the name of any of its affiliates or (y) the terms of the Investor’s
investment in the Company and/or any of the Company’s affiliates, in each case, in any future news release, advertisement,
roadshow, marketing presentation, public filing or other publicity or marketing materials by the Company, LoanCore Advisors, LLC
or LoanCore Capital, LLC or any of their respective affiliates, without the prior written consent of the Investor; provided,
however, that the inclusion of any information contained in the IPO Registration Statement in any of the foregoing materials
shall not be subject to such prior written consent requirement; provided, further, that the inclusion of any information
referenced in clause (x) or (y) in any publicity or marketing materials shall require prior written notice to the Investor (with
the Investor having an opportunity to object to the description of the Investor in such materials) notwithstanding such information
being included in the IPO Registration Statement.


 


SECTION 5.2  Confidentiality.
Each of the Company, LoanCore Advisors, LLC and LoanCore Capital, LLC, on behalf of themselves and their respective employees,
members, partners, managers, principals, agents and other representatives, acknowledge that the terms of the Investor’s investment
in the Company and/or any of the Company’s affiliates (x) is confidential and each agrees not to share it with any person
or entity without the prior written consent of Investor, except for disclosures (i) to legal counsel, accountants and other professional
advisors to the Company, LoanCore Advisors, LLC or LoanCore Capital, LLC who need to know such terms and so long as such persons
agree to maintain the confidential nature thereof or (ii) as otherwise required by applicable law, rule, regulation or order and
(y) shall not be disclosed, reproduced, used, or distributed except as set forth in the prior clause or Section 5.1. Notwithstanding
the foregoing, the parties hereto acknowledge that the transactions contemplated in this Agreement have been disclosed in the IPO
Registration Statement and that a form of this Agreement has been filed as an exhibit to the IPO Registration Statement. The parties
hereto agree that money damages would not be a sufficient remedy for any breach or threatened breach of this Section 5.2 and that
in addition to all other remedies the Investor may be entitled to under this Agreement or applicable law (which the Investor does
not waive by the exercise of any rights hereunder), the Investor shall be entitled to seek specific performance and injunctive
or other equitable relief as a remedy for any such breach or threatened breach of this Section 5.2 and the parties hereby waive
any requirement for the showing of any actual monetary damages in connection with seeking such relief.


 


ARTICLE VI


 


TERMINATION


 


SECTION 6.1  Term. This Agreement
shall automatically terminate upon the later of (i) the date on which the Investor ceases to Beneficially Own shares of stock representing
5.0% or more of the outstanding Common Stock and (ii) the termination of the Investor Affiliate’s right to receive a share
of the revenues described in the Revenue Letter Agreement.


 


SECTION 6.2  Survival. If this
Agreement is terminated pursuant to Section 6.1, this Agreement shall become void and of no further force and effect; provided,
however, that Sections 5.1 and 5.2 shall survive any termination of this Agreement and shall continue so long as the Investor
Beneficially Owns any Common Stock.


 



    	6



    	 



    




ARTICLE VII


 


REPRESENTATIONS AND WARRANTIES


 


SECTION 7.1  Representations and
Warranties of the Investor. The Investor represents and warrants to the Company and the Management Investors that: (a)
the Investor is duly authorized to execute, deliver and perform this Agreement; (b) this Agreement has been duly executed by the
Investor or its attorney-in-fact on behalf of the Investor and, upon execution by the parties hereto other than the Investor, will
be the legal, valid and binding agreement of the Investor, enforceable against the Investor in accordance with its terms, except
as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and by general principles of equity; and (c) the execution, delivery and performance by the Investor of this Agreement
does not violate or conflict with or result in a breach of or constitute (or with notice or lapse of time or both would constitute)
a default under any material agreement to which the Investor is a party or the organizational documents of the Investor.


 


SECTION 7.2  Representations and
Warranties of the Company. The Company represents and warrants to the Investor and the Management Investors that: (a)
the Company is duly authorized to execute, deliver and perform this Agreement; (b) this Agreement has been duly authorized, executed
and delivered by the Company and, upon execution by the parties hereto other than the Company, will be the legal, valid and binding
agreement of the Company, enforceable against the Company in accordance with its terms, except as enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and
by general principles of equity; and (c) the execution, delivery and performance by the Company of this Agreement does not violate
or conflict with or result in a breach by the Company of or constitute (or with notice or lapse of time or both would constitute)
a default by the Company under its charter or bylaws, any existing applicable law of any court, administrative agency, regulatory
body, commission or other governmental authority, board, bureau or instrumentality, domestic or foreign and any subdivision thereof,
exercising any statutory or regulatory authority of any of the foregoing, domestic or foreign, having jurisdiction over the Company,
or any material agreement or instrument by which the Company or any of its assets may be bound.


 


SECTION 7.3  Representations and
Warranties of each Management Investor. Each Management Investor represents and warrants, severally and not jointly, to the
Company and the Investor that: (a) he is legally competent to execute this Agreement; (b) this Agreement has been duly executed
by such Management Investor or his attorney-in-fact on behalf of such Management Investor and is a valid and binding agreement
of such Management Investor, enforceable against such Management Investor in accordance with its terms; and (c) the execution,
delivery and performance by such Management Investor of this Agreement does not violate or conflict with or result in a breach
of or constitute (or with notice or lapse of time or both would constitute) a default under any agreement to which such Management
Investor is a party.


 


ARTICLE VIII


 


NOTIFICATION OF REDEMPTION OR REPURCHASE


 


SECTION 8.1  Notice of Redemption
or Repurchase of Common Stock. Because the Board has granted the Investor an exemption from the Share Ownership Limit
(as such term is defined in the Articles) such that the Investor has an Excepted Holders Limit (as defined in the Articles) of
30%, the Company Agrees that, in the event the Company plans to redeem or repurchase shares of Common Stock in an amount that would,
if such redemption or repurchase is consummated, cause the Investor’s ownership of Common Stock to exceed the Investor’s
Excepted Holder Limit, then the Company will promptly provide notice to the Investor of such redemption or repurchase, as the case
may be.


 



    	7



    	 



    




ARTICLE IX


 


MISCELLANEOUS


 


SECTION 9.1  Notices. All notices,
requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument
delivered in person or sent by facsimile (provided a copy is thereafter promptly delivered as provided in this Section 9.1) or
nationally recognized overnight courier, addressed to such party at the address or facsimile number set forth below or such other
address or facsimile number as may hereafter be designated in writing by such party to the other parties:


 


(a) if to the Company, to:


 


LoanCore Realty Trust, Inc. 


55 Railroad Avenue, Suite 100 


Greenwich, Connecticut 06830 


Telephone: (203) 861-6010 


Facsimile: (203) 861-6006 


Attention: Jordan Bock


 


with a copy to:


 


Sidley Austin LLP 


787 Seventh Avenue 


New York, New York 10019 


Telephone: (212) 839-5300 


Facsimile: (212) 839-5599 


Attention: Edward F. Petrosky, Esq. 


J. Gerard Cummins, Esq.


 


(b) if to the Investor, to:


 


LC REIT LLC 


335 Madison Avenue, 24th Floor 


New York, New York 10017 


Telephone: (646) 658-2200

Facsimile: (646) 658-2122

Attention: Jesse Hom


 


(c) if to any Management Investor, to:


 


c/o LoanCore Realty Trust, Inc. 


55 Railroad Avenue, Suite 100 


Greenwich, Connecticut 06830 


Telephone: (203) 861-6010 


Facsimile: (203) 861-6006 


Attention: Management Investor


 



    	8



    	 



    




SECTION 9.2  Interpretation.
The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement. Whenever the words “included”, “includes” or “including” are used in this
Agreement, they shall be deemed to be followed by the words “without limitation”.


 


SECTION 9.3  Severability. In
case any provision of this Agreement shall be found by a court of law to be invalid, illegal, or unenforceable, the validity, legality,
and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.


 


SECTION 9.4  Counterparts. This
Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all
of which taken together shall constitute one and the same instrument. This Agreement or any counterpart may be executed via facsimile
transmission or pdf, and any such executed facsimile or pdf copy shall be treated as an original.


 


SECTION 9.5  Entire Agreement; No
Third Party Beneficiaries. This Agreement (a) constitutes the entire agreement and supersedes all other prior agreements, both
written and oral, among the parties with respect to the subject matter hereof and (b) is intended for the benefit of the parties
hereto and their respective permitted successors and assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.


 


SECTION 9.6  Further Assurances.
Each party shall execute, deliver, acknowledge and file such other documents and take such further actions as may be reasonably
requested from time to time by the other parties hereto to give effect to and carry out the transactions contemplated herein.


 


SECTION 9.7  Governing Law. This
Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. The parties hereby agree that
any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced
in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
submit to such jurisdiction, which jurisdiction shall be exclusive. The parties hereby waive any objection to such exclusive jurisdiction
and agree not to plead or claim that such courts represent an inconvenient forum.


 


SECTION 9.8  Amendments; Waivers.


 


(a)    This Agreement may not be amended,
modified or waived, in whole or in part, except by an agreement in writing signed by each of the parties hereto.


 


(b)    No failure or delay by any party
in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies
herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.


 


SECTION 9.9  Assignment. Neither
this Agreement nor any of the rights or obligations hereunder shall be assigned by any of the parties hereto without the prior
written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit
of and be enforceable by the parties and their respective successors and assigns; provided, however, that the Investor
shall be permitted, without the prior written consent of the other parties, to assign all or a portion of its respective rights
and obligations hereunder to one or more investment vehicle(s) under common control with the Investor in connection with the corresponding
transfer of all or a portion of the Investor’s Common Stock, in which case, such vehicle(s) shall become a party to this
Agreement and such vehicle(s) shall constitute the “Investor” for all purposes hereunder.


 


[Signature Page Follows]






    	9



    	 



    

 


IN WITNESS WHEREOF, the parties have caused
this Agreement to be duly executed and delivered, all as of the date first set forth above.


 


 


	LOANCORE REALTY TRUST, INC.	 
	 	 	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 
	 	 	 
	LOANCORE ADVISORS, LLC	 
	 	 	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 
	 	 	 
	LOANCORE CAPITAL, LLC	 
	 	 	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 



 



    	10



    	 



    




Agreed solely with respect to Article III:


 


	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Mark Finerman	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Christopher McCormack	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Daniel Bennett	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Jordan Bock	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Gary Berkman	 



 



    	11



    	 



    




	 	LC REIT LLC	 
	 	 	 	 
	 	 	 	 
	 	By:	NA-RE INVESTMENT HOLDINGS,
        LLC, 

its sole member	 
	 	 	 	 
	 	 	 	 
	 	By:	GIC Real Estate, Inc., 

its Manager	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 






 



    	12